CapsoVision (CV) Change in Accured Expenses (2024 - 2025)

CapsoVision's (CV) quarterly Change in Accured Expenses came in at -$92000.0 in Q4 2025, up 86.57% year-on-year from -$49311.4 in Q4 2024, and down 107.66% quarter-over-quarter from $1.2 million in Q3 2025.

CapsoVision (CV) Change in Accured Expenses (2024 - 2025) Analysis & Trends

CapsoVision has disclosed Change in Accured Expenses across 2 years of filings, most recently posting -$92000.0 for Q4 2025.

  • Change in Accured Expenses for Q4 2025 came in at -$92000.0, up 86.57% year-over-year; the trailing twelve-month figure through Dec 2025 was -$404000.0 (changed N/A YoY), and the FY2025 annual result was $2.1 million, up 1143.14% from the prior year.
  • Change in Accured Expenses came in at -$92000.0 for Q4 2025 at CapsoVision, down from $1.2 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.2 million in Q3 2025 to a low of -$828000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -654.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 703.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -347.10 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 21.07 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 145.10 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -250.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 74.30 Mn
10 CapsoVision 161.82 Mn 151.71 Mn 1.95 Mn -92,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -92,000.00
Dec 31, 2025 -92,000.00
Sep 30, 2025 1.20 Mn
Sep 30, 2025 1.20 Mn
Dec 31, 2024 -685,000.00
Dec 31, 2024 -685,000.00
Sep 30, 2024 -828,000.00
Sep 30, 2024 -828,000.00